These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31331572)

  • 1. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial.
    Amiri M; Navabi J; Shokoohinia Y; Heydarpour F; Bahrami G; Behbood L; Derakhshandeh P; Momtaz S; Farzaei MH
    Complement Ther Med; 2019 Aug; 45():262-268. PubMed ID: 31331572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial.
    Derakhshande P; Navabi SJ; Shokoohinia Y; Rouhi-Broujeni H; Deris F; Behbood L; Shahbazi F; Amiri M; Farzaei MH
    J Complement Integr Med; 2019 Aug; 16(4):. PubMed ID: 31442203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
    Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
    AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.
    Langmead L; Feakins RM; Goldthorpe S; Holt H; Tsironi E; De Silva A; Jewell DP; Rampton DS
    Aliment Pharmacol Ther; 2004 Apr; 19(7):739-47. PubMed ID: 15043514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Irving PM; Iqbal T; Nwokolo C; Subramanian S; Bloom S; Prasad N; Hart A; Murray C; Lindsay JO; Taylor A; Barron R; Wright S
    Inflamm Bowel Dis; 2018 Mar; 24(4):714-724. PubMed ID: 29538683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of hydro-alcoholic extract of Achillea wilhelmsii C. Koch on indomethacin-induced gastric ulcer in rats: a proteomic and metabolomic approach.
    Koushki M; Farrokhi Yekta R; Amiri-Dashatan N; Dadpay M; Goshadrou F
    BMC Complement Altern Med; 2019 Aug; 19(1):205. PubMed ID: 31391093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
    Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
    Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative and apoptosis inducing potential of hydroalcoholic Achillea wilhelmsii C. Koch extract on human breast adenocarcinoma cell lines MCF-7 and MDA-Mb-468.
    Galavi HR; Saravani R; Shahraki A; Ashtiani M
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2397-2403. PubMed ID: 28167484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of optimal extraction, antioxidant, and antimicrobial activities of Achillea biebersteinii and A. wilhelmsii.
    Bashi DS; Fazly Bazzaz BS; Sahebkar A; Karimkhani MM; Ahmadi A
    Pharm Biol; 2012 Sep; 50(9):1168-76. PubMed ID: 22881142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
    Vermeire S; Sandborn WJ; Danese S; Hébuterne X; Salzberg BA; Klopocka M; Tarabar D; Vanasek T; Greguš M; Hellstern PA; Kim JS; Sparrow MP; Gorelick KJ; Hinz M; Ahmad A; Pradhan V; Hassan-Zahraee M; Clare R; Cataldi F; Reinisch W
    Lancet; 2017 Jul; 390(10090):135-144. PubMed ID: 28527704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial.
    Ben-Arye E; Goldin E; Wengrower D; Stamper A; Kohn R; Berry E
    Scand J Gastroenterol; 2002 Apr; 37(4):444-9. PubMed ID: 11989836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease.
    Khazneh E; Hřibová P; Hošek J; Suchý P; Kollár P; Pražanová G; Muselík J; Hanaková Z; Václavík J; Miłek M; Legáth J; Šmejkal K
    Molecules; 2016 Mar; 21(4):404. PubMed ID: 27023504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
    Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M
    Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.
    Henn MR; O'Brien EJ; Diao L; Feagan BG; Sandborn WJ; Huttenhower C; Wortman JR; McGovern BH; Wang-Weigand S; Lichter DI; Chafee M; Ford CB; Bernardo P; Zhao P; Simmons S; Tomlinson AD; Cook DN; Pomerantz RJ; Misra BK; Auninš JG; Trucksis M
    Gastroenterology; 2021 Jan; 160(1):115-127.e30. PubMed ID: 32763240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
    Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
    J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study.
    Agraib LM; Yamani MI; Tayyem R; Abu-Sneineh AT; Rayyan YM
    Clin Nutr ESPEN; 2022 Oct; 51():83-91. PubMed ID: 36184252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.